Abstract
COVID-19 is a world public health emergency caused by the new coronavirus, SARSCoV-2. Many drugs were repurposed as a treatment for COVID-19 patients including Chloroquine (CQ). CQ is a bitter taste receptor agonist reported to relax the airways suggesting a role in preventing disease severity of COVID-19 patients with asthma.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Asthma, Chloroquine, Airway relaxation, bitter taste receptor agonist, bronchodilation, TAS2R, 【초록키워드】 drug, airway, severity of COVID-19, Patient, receptor, public health emergency, SARSCoV-2, New coronavirus, bitter taste, caused, reported, preventing disease, treatment for COVID-19, 【제목키워드】 receptor, bitter taste,
【저자키워드】 COVID-19, SARS-CoV-2, Asthma, Chloroquine, Airway relaxation, bitter taste receptor agonist, bronchodilation, TAS2R, 【초록키워드】 drug, airway, severity of COVID-19, Patient, receptor, public health emergency, SARSCoV-2, New coronavirus, bitter taste, caused, reported, preventing disease, treatment for COVID-19, 【제목키워드】 receptor, bitter taste,